Revenue: The sum of all revenue fields included for a company's operating activities.
Inovio Pharmaceuticals, Inc. (INO) had Revenue of $0.22M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.22M |
$-107.25M |
|
-- |
|
$0.22M |
|
$112.62M |
|
$-112.40M |
|
$5.14M |
|
$-107.25M |
|
$-107.25M |
|
$-107.25M |
|
$-107.25M |
|
$-107.25M |
|
$-107.25M |
|
$-112.40M |
|
$-109.27M |
|
27.16M |
|
27.16M |
|
$-3.95 |
|
$-3.95 |
|
| Balance Sheet Financials | |
$97.83M |
|
$3.66M |
|
$15.37M |
|
$113.20M |
|
$35.33M |
|
-- |
|
$9.37M |
|
$44.69M |
|
$68.50M |
|
$68.50M |
|
$68.50M |
|
36.10M |
|
| Cash Flow Statement Financials | |
$-104.08M |
|
$104.07M |
|
$51.48M |
|
$14.31M |
|
$65.81M |
|
$51.50M |
|
$6.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-51616.91% |
|
-51616.91% |
|
-50179.50% |
|
-49254.27% |
|
-49254.27% |
|
$-104.51M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.18 |
|
2009.84 |
|
-156.57% |
|
-156.57% |
|
-94.75% |
|
-156.57% |
|
$1.90 |
|
$-3.85 |
|
$-3.83 |
|